Stem Cells for Hope

Welcome to our website & discussion forums

Home     Stem Cells 101   Treatable Conditions   Patients' Experiences   Forums    Contact      FAQ
Monday, September 27, 2010 10:51:30 PM 
  Home Forums Help Search Login Register Contact Us  

Multisystem atrophy

Multisystem atrophy
(MSA) is a group of rare, multisystem degenerative diseases that have several clinical features of Parkinson's disease and are sometimes referred to as the "Parkinsonism-plus syndromes."

When MSA was first identified in 1960, it was named "Shy-Drager Syndrome" after the two physicians who first described its symptoms. Now, Shy-Drager Syndrome is recognized as one of three manifestations of multisystem atrophy. The other two are striatonigral degeneration and olivopontocerebellar atrophy (OPCA). The three are classified together because of their clinical overlap and neuroanatomical similiarities.

Multisystem atrophy has three cardinal features:

    * Parkinsonism (see Parkinson's disease)
    * Autonomic failure (including orthostatic hypotension, erectile dysfunction, and urinary incontinence or retention)
    * Cerebellar ataxia (failure of muscular coordination)

All three characteristics occur in the majority of MSA cases, but with considerable variation with regards to specific attributes, and any one of the three may predominate. If autonomic failure predominates, MSA is known as Shy-Drager Syndrome. If parkinsonism predominates, it is known as striatonigral degeneration. Striatonigral degeneration is usually indistinguishable from Parkinson's disease, except that it does not respond to Parkinson's treatment. If cerebellar ataxia predominates, MSA is known as olivopontocerebellar atrophy (OPCA).

Although cognitive dysfunction may appear minimal, most patients do experience frontal system impairment and many develop dementia late in the course of the disease. MSA is generally more severe than Parkinson's. More than 40% of MSA patients are confined to a wheelchair or otherwise severely disabled within 5 years of initial diagnosis. Except in a few cases, the drug of choice for Parkinson's patients (levedopa) has no effect on MSA and may even worsen symptoms.

Incidence and Prevalence

MSA affects men twice as often as women. The average age of onset is 50 years old, and the average survival time after initial diagnosis is 10 years. As many as 10% of Parkinson's cases that are diagnosed incorrectly are identified as MSA upon autopsy.

Anatomy of MSA

The underlying neurological anatomy of MSA is similar to that of Parkinson's disease, but with some noticeable and important differences. These differences can often, though not always, be seen on CT scan or MRI scan of the brain.

Even though each form of MSA is associated with its own characteristic anatomical abnormalities, they all share one thing in common: the presence of particular types of what are known as "inclusions." An inclusion is the presence of a foreign or abnormal substance inside a cell, in this case the neurons and glia cells, two different types of nervous system cells. However, the particular type of inclusion that is characteristic of MSA, is also found in other unrelated disorders.

Biochemically, MSA patients usually have a substantial reduction in dopamine and noradrenaline levels, as well as low levels of other neurochemicals

Mission Statement

Our mission is to educate the general public on stem cell therapies now available to treat common neurological diseases and injuries.

Navigate Our Site
Stem Cells 101 Stem Cells 101
This page will explain stem cell therapies.  It answer many questions you may have regarding stem cell therapy for many common neurological disorders, such as Parkinson's disease, stroke and multiple sclerosis
Patients' Experiences Patients' Experiences
This page will share patient's experiences.  We expect this page to grow as more people participate.
Treatable Conditions Treatable Conditions
An informative that lists conditions that may be treated with stem cell therapies.
Frequently asked Questions FAQ
Frequently asked questions regarding stem cell therapies. This is a forum discussion, so if you are a registered member, you can ask questions here.
Forums Forums
Our discussion forums which act as a community for people who are interested in stem cell therapies, who have personal experiences to share, and who have questions to ask.

Contact Us

Contact Us
Please contact us with any questions or comments you may have regarding stem cell therapies or our website.

Join our forums!  Login (Forgot your password?)